Diligence memo · auto-generated · as of July 2, 2026
Clytusan Corp Inc.
Clytusan Corp Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Clytusan Corp Inc. operates in Biotechnology, based in MORRISVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Clytusan Corp Inc. has raised $10M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $10M on 2021-11-03.
Most recent recorded round closed around 2021-11-03.
Valuation (modeled)modeled
Provath models Clytusan Corp Inc. at approximately $194M (range $11M–$775M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.07× the median modeled value of Series A Biotechnology companies in 2019–2021 (216 peers) — value vs value, same stage and era. Within the normal band (107% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 4.7 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 57% of Biotechnology peers (4293 compared).
Modeled value ranks above 72% of those peers.
Closest niche peers: TRACT Therapeutics, Inc., TechAccel, LLC, Arrakis Therapeutics, Inc., Trident Labs, Inc., Meissa Vaccines Inc.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.